Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Inventory Average (2016 - 2023)

Historic Inventory Average for Perspective Therapeutics (CATX) over the last 12 years, with Q3 2023 value amounting to $1.1 million.

  • Perspective Therapeutics' Inventory Average fell 2855.21% to $1.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.1 million, marking a year-over-year decrease of 2855.21%. This contributed to the annual value of $1.4 million for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Perspective Therapeutics' Inventory Average stood at $1.1 million, which was down 2855.21% from $1.3 million recorded in Q2 2023.
  • Over the past 5 years, Perspective Therapeutics' Inventory Average peaked at $1.5 million during Q4 2022, and registered a low of $513500.0 during Q1 2019.
  • Over the past 5 years, Perspective Therapeutics' median Inventory Average value was $855500.0 (recorded in 2021), while the average stood at $908184.2.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 6294.03% in 2021, then crashed by 2855.21% in 2023.
  • Over the past 5 years, Perspective Therapeutics' Inventory Average (Quarter) stood at $523000.0 in 2019, then grew by 24.86% to $653000.0 in 2020, then surged by 62.94% to $1.1 million in 2021, then soared by 39.19% to $1.5 million in 2022, then fell by 28.87% to $1.1 million in 2023.
  • Its Inventory Average stands at $1.1 million for Q3 2023, versus $1.3 million for Q2 2023 and $1.4 million for Q1 2023.